Currently, out of the existing stock ratings of Jason Butler - 194 which are a Buy (94.63%), 11 which are a Hold (5.37%)

Jason Butler

Work Performance Price Targets & Ratings Chart

Analyst Jason Butler works at JMP and is covering Healthcare, Industrials sectors with 406 price targets and ratings displayed on 39 stocks.

Jason Butler's average stock forecast success ratio is 29.53% with an average time for price targets to be met of 161.74 days.

Most recent stock forecast was given on AQST, Aquestive Therapeutics at 21-Sep-2023.

Wall Street Analyst Jason Butler

Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for TRVN (TREVENA) at 3/31/2023. The price target of $2 was fulfilled within 38 days with a profit of $1.3 (185.71%) receiving and performance score of 48.87.

Average potential price target upside

of $44.58 (43.38%) on KRTX (KARUNA THERAPEUTICS).
of $33.57 (21.16%) on ARGX (ARGENX SE).
of $29.2 (72.8%) on ESPR (ESPERION THERAPEUTICS).

ACAD ACADIA Pharmaceuticals ADMS Adamas Pharmaceuticals ARGX argenx SE ARNA Arena Pharmaceuticals AXGT CRMD CorMedix CYTK Cytokinetics ESPR Esperion Therapeutics HALO Halozyme Therapeutics ITCI IntraCellular Therapies KRTX Karuna Therapeutics NEOS NERV Minerva Neurosciences RZLT SYRS VNDA Vanda Pharmaceuticals XON ZFGN MYOV Myovant Sciences Ltd PLXP AMTI Applied Molecular Transport AQST Aquestive Therapeutics ATHA Athira Pharma AXON Axon Enterprise CRTX Cortexyme ENTA Enanta Pharmaceuticals HOOK HOOKIPA Pharma LRMR PGEN GMDA Gamida Cell Ltd MRNS CNCE Concert Pharmaceuticals MOR OVID Ovid Therapeutics PRTO QNRX TRVN Trevena VRDN ZGNX Zogenix

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Jeffrey Hung (MORGAN STANLEY)